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Abstract
Background: We previously reported that asthmatic children with GSTM1 null genotype may be more susceptible
to the acute effect of ozone on the small airways and might benefit from antioxidant supplementation. This study
aims to assess the acute effect of ozone on lung function (FEF25-75) in asthmatic children according to dietary
intake of vitamin C and the number of putative risk alleles in three antioxidant genes: GSTM1, GSTP1 (rs1695), and
NQO1 (rs1800566).
Methods: 257 asthmatic children from two cohort studies conducted in Mexico City were included. Stratified linear
mixed models with random intercepts and random slopes on ozone were used. Potential confounding by ethnicity
was assessed. Analyses were conducted under single gene and genotype score approaches.
Results: The change in FEF25-75 per interquartile range (60 ppb) of ozone in persistent asthmatic children with low
vitamin C intake and GSTM1 null was −91.2 ml/s (p =0.06). Persistent asthmatic children with 4 to 6 risk alleles and
low vitamin C intake showed an average decrement in FEF25-75 of 97.2 ml/s per 60 ppb of ozone (p = 0.03). In
contrast in children with 1 to 3 risk alleles, acute effects of ozone on FEF25-75 did not differ by vitamin C intake.
Conclusions: Our results provide further evidence that asthmatic children predicted to have compromised
antioxidant defense by virtue of genetic susceptibility combined with deficient antioxidant intake may be at
increased risk of adverse effects of ozone on pulmonary function.
Keywords: Air pollution, Asthmatic children, Antioxidant genes, Mexico City, Vitamin C
Background
Ozone is a potent oxidant that easily reaches the lung lining
fluid compartment [1] providing an additional
a source of
reactive oxygen species and causing, among other out-
comes, reversible declines in lung function [2]. Vitamin C
is an exogenous nonenzymatic antioxidant that participates
in the primary lung defense against reactive oxygen species
[3]. Several epidemiological studies have suggested that a
diet rich in antioxidants may lessen the effect of ozone on
respiratory health of susceptible populations [4,5].
With respect to genetics, epidemiological studies have
shown that the effect of ozone on the respiratory health of
asthmatic children may be modulated by the functional
genetic polymorphisms of antioxidant genes such as
Glutathione S-transferase (GST) M1,( GST)P1,a n dNQO1
[6,7]. These genes code for phase II xenobiotic detoxifying
enzymes that participate in the intracellular defense
against oxidative stress. They are members of the Nrf2
pathway, responsible for the expression of enzymes that
conjugate and inactivate reactive oxygen species [8].
In a randomized controlled trial of antioxidant supple-
mentation (vitamin C and E) among asthmatic children in
Mexico City, we reported that children in the placebo
group with GSTM1 null genotype may be more vulnerable
to the adverse effects of ozone on lung function than
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those with GSTM1 positive genotype, regardless of the
treatment group [9]. In the previous analysis, GSTM1 was
classified as null versus positive. In the current analysis,
the number of copies of GSTM1 (0, 1 or 2) was quantified;
and we examined whether dietary intake of vitamin C in
combination with common functional variants in three
antioxidant genes (GSTM1, GSTP1 and NQO1)i n f l u e n c e s
the relationship between ozone exposure and lung func-
tion (FEF25-75) in Mexican asthmatic children exposed to
high ozone levels. In addition to examining the functional
polymorphisms in these three antioxidant genes sepa-
rately, we created a putative antioxidant deficiency genetic
risk score by combining genotypes across them.
Methods and materials
See Additional file 1 for further explanation of the
methods mentioned below.
Study subjects
The study methods have been described previously [10]. In
brief, 158 asthmatic children were recruited through the
Hospital Infantil “Federico Gómez” (México City, México)
between October 1998 and April 2000. At baseline,
children randomly received either supplement (vita-
min C 250 mg+vitamin E 50 mg per day) or placebo
in a double-blind manner over a 12-week period follow-
up. We also collected blood samples and diet information
at baseline. We henceforth refer to this study as “Antioxi-
dants”.I nt h e“EVA”
b study, 158 asthmatic children were
recruited from June 2003 to June 2005 at the same hos-
pital under a similar protocol [11], but with no antioxidant
intervention. After combining the two studies, a total of
257 participants with an adequate DNA sample and diet
information were available for analysis. In the “Antioxi-
dants” study, children performed two spirometric tests per
week during 12 weeks. Children who participated in the
“EVA” study performed spirometric tests every two weeks
during 16 weeks. Spirometry was performed in accor-
dance with the American Thoracic Society (ATS) specifi-
cation [12] using an Easy One spirometer (NDD Medical
Technologies, Andover, MA, USA). Children underwent
skin testing to determine atopy. Given that the maximum
site of effect of acute exposure to ozone in the human
lung is at the level of small airways [13], and since a
variety of epidemiological studies have reported an asso-
ciation between ozone exposure and impaired function of
the small airways [10,14,15], the outcome of interest was
FEF25-75. Over the follow-up we collected 4,548 measure-
ments of FEF25-75 (Figure 1). Parents provided written
informed consent. The studies protocols were reviewed
and approved by ethics committees at the Instituto
1998  2003 2004 2000 
Antioxidants ( n=144) EVA (n=113)
￿12 weeks
￿24 spirometric tests
(3164 repeated measures)
￿Randomized trial
(placebo vs. Supplement)
￿GSTM1 , GSTP1 genotypes
for 144 children
￿NQO1 genotype for 139 
children 
￿16 weeks
￿8s p i r o m e t r i ct e s t s
(1384 repeated measures)
￿Observational study
￿GSTM1, GSTP1 genotypes
for 113 children
￿NQO1 genotype for 60 
children  
At baseline: 
￿Asthma diagnosis
￿FFQ
￿Blood sample
￿Skin test
Figure 1 Study design. In the antioxidant study, asthmatic children were recruited from 1998 to 2000 and followed during 12 weeks with
spirometric tests during the follow-up. At baseline, children were randomly assigned to either a placebo or a supplementation group (vitamin C
250 mg/day and vitamin E 50 mg/day). In the EVA study, asthmatic children were recruited and followed during 16 weeks from 2003 to 2004.
Every two weeks children had a spirometric test. In both studies, children provided blood sample at baseline.
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and the National Institute of Environmental Health
Sciences.
Asthma status and severity were confirmed by a pediatric
allergist using Global Initiative for Asthma (GINA)
guidelines [16]. Severity was rated as intermittent or
persistent (mild, moderate, or severe). Ozone exposure
(1-h maximum) and daily temperature were characterized
from the measurements at the monitoring station closest
to each child’sh o m e .
Diet
In the “Antioxidants” cohort, at baseline, children were ran-
domly assigned (double-blind) to receive either placebo or
supplement (vitamins C and E). EVA was an observational
study; thus, there was no controlled supplementation.
Individual dietary intake was assessed using a version of
the validated food frequency questionnaire developed by
Willett [17] adapted to the Mexican population. Vitamin
C intake was adjusted for total caloric intake [18]. Intake
was increased by 250 mg/day for children assigned to the
supplementation group or by the reported intake for those
taking supplements.
Genotyping
Genotyping was performed for the GSTM1, GSTP1
(rs1695), and NQO1 (rs1800566) polymorphisms, using
polymerase chain reaction-based methods. 257 children
were genotyped for GSTM1 and GSTP1; a subset of 199
children was also genotyped for NQO1, having participated
in a parallel study of nuclear families [19]. In 160 of
the asthmatic children with additional genotype data
available, individual ancestry proportions were estimated
using the program FRAPPE [20] based on three ancestral
populations: Native-American, European, and African [21].
Statistical analysis
Since children from the EVA cohort did not receive
antioxidant supplementation, they were considered
similar to children taking placebo in the Antioxidant
cohort. We verified that these two groups did not differ in
genotype frequencies. Vitamin C intake was dichotomized
in this combined group using the median intake
(105 mg/d). Children receiving supplementation, as
part of the “Antioxidant” study, were classified into a
higher intake group which had more than 280 mg/d.
Thus, according to the distribution of vitamin C intake, we
had three levels: (30–105), (>105-226), and (280-477 mg/day),
hereafter referred to as “low”, “medium”,a n d“high” vitamin
C, respectively.
We first analyzed the relationship between ozone expo-
sure and FEF25-75 separately for each genotype of the three
genes separately. Given that the relationships between the
outcome and the concentrations of ozone in children with
1o r2GSTM1 copies were similar each other but different
to the observed in children with 0 copies (null genotype),
we collapsed GSTM1 into null and positive. A similar
situation was observed for GSTP1 and NQO1 genotypes.
Thus, we defined “at genetic risk” (GR) and “not at genetic
risk” (NGR) groups as follows: GSTM1 null versus posi-
tive; GSTP1 Val/Val versus Ile/Val+Ile/Ile, and NQO1
Pro/Pro versus Pro/Ser+Ser/Ser.
After combining genotype and vitamin C intake, six
strata were formed: (GR-low diet), (GR-medium),
(GR-high), (NGR-low), (NGR-medium), and, (NGR-high)
for each gene.
Subsequently, genes were grouped to create a putative
antioxidant susceptibility genetic risk score by counting
the number of risk alleles. Genotype score analysis
included only children with complete genotype for all
genotypes (n=199). The creation of this index is detailed
in Additional file 1: Table S1. We first explored the rela-
tionship between the outcome and ozone exposure within
four genetic risk score groups collapsed because of sample
size: 1 or 2 risk alleles; 3; 4; and 5 or 6. Since we observed
that children with 3 risk alleles had similar response to the
1–2 risk alleles group and children with 4 risk alleles had
similar response to children in the 5–6 risk allele group,
we formed only two groups: 1 to 3, and 4 to 6 risk alleles.
Additionally, given that no significant effect of ozone on
FEF25-75 was observed in children with “medium” or
“high” vitamin C groups, they were combined in a single
“high” level for greater stability of estimates.
Thus, from the combination between the two suscepti-
bility categories (1 to 3 or 4 to 6 risk alleles) and the two
levels of vitamin C intake (low-high), four strata were
formed: (1 to 3-low), (1 to 3-high), (4 to 6-low), and
(4 to 6-high).
We analyzed all asthmatic children together and also
grouped children with mild-persistent, moderate-persistent,
and severe-persistent asthma into a “persistent” asthmatic
group, which was analyzed separately.
To investigate whether vitamin C intake plus geno-
type modulates the relationship between ozone expo-
sure and lung function, stratified linear mixed models
with random intercept and random slope on ozone
were fit in the whole sample and into the “persistent”
group alone as well.
The stratified models were adjusted for age, gender,
body mass index, height, time, cohort (Antioxidants or
EVA), use of bronchodilator, and previous day mini-
mum temperature. Previous day’s1 - hm a x i m u m
ozone was the exposure. Effect estimates were calcu-
lated per interquartile range (IQR), which was 60 ppb.
Genotype effect was calculated as the difference in coeffi-
cients for FEF25-75 in relation to ozone by genotype group.
Diet effect was calculated as the difference between these
coefficients between vitamin C groups.
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using exclusively the subsample of 160 children with eth-
nicity information. The association between each poly-
morphism and FEF25-75 was assessed through two linear
mixed models. The first model was adjusted for age,
gender, body mass index, height, time, cohort, use of
bronchodilator, and previous day minimum temperature.
The second model was also adjusted for Native-American
ancestry but ancestry was not associated with the outcome
and thus was not a confounder and was not retained in
final models. Analysis was conducted using R software
(version 2.9.1; the R foundation for Statistical Computing).
Results
The final sample was composed of 144 (56%) participants
from “Antioxidants” and 113 (44%) from “EVA” study.
Major baseline characteristics of the study population are
shown in Table 1. One third of the sample (30.4%) had
antioxidant supplementation in the randomized controlled
trial [10]. Persistent asthma was diagnosed in 164 of 257
children (63.8%). The prevalence of the GSTM1 null geno-
type was 36.2%; 33.1% of children had the GSTP1 Val/Val;
and 33.7% had the NQO1 Pro/Pro. Baseline characteris-
tics, as well as ozone exposure and vitamin C intake, were
homogeneously distributed among the genotypes of each
polymorphism (Additional file 1: Table S2). Average
ancestry proportions were 70.9% Native-American, 26.2%
European, and 2.9% African.
Ozone exposure
The 1-h maximum ranged from 10 to 309 ppb with a
mean of 96.9 ppb. The Mexican standard (110 ppb
1 h maximum) was exceeded on 30.7% of the days.
(Additional file 1: Table S3).
Ozone effects by genotype group –All asthmatics
We found no overall effect of ozone on FEF25-75 (−3.3 ml/s;
p=0.76). In analyses by genotype, asthmatic children with
the GSTM1 null genotype appeared to experience a
stronger ozone effect on lung function (−25.8 ml/s;
p=0.13; n=93) than children with one (3.9 ml/s; p=0.80;
n=129) or two (22.2 ml/s: p=0.48; n=35) copies. These
results suggest a positive linear trend between the number
of GSTM1 copies and the average change in FEF25-75 in
response to ozone exposure (p-trend=0.09). We did not
identify a potential susceptible group by GSTP1 genotypes.
(Additional file 1: Table S4).
Ozone effects by genotype group -persistent asthmatics
We found no overall effect of ozone on FEF25-75
(−16.2 ml/s; p= 0.55). Children with no GSTM1 copy
appeared to have stronger ozone-induced FEF25-75
decrements (−36.6 ml/s; p= 0.05; n =65) than children
with one (−15.0 ml/s; p=0.42; n =81) or two copies
(23.7 ml/s; p=0.59; n =18) (p-trend =0.10). We did not
identify a potential susceptible group by GSTP1 or
NQO1 genotypes (Additional file 1: Table S4).
Vitamin C intake
Recommended Daily Intake (RDI, 45 mg/day) by gender
and age was exceeded for all but one child.
Table 1 Characteristics of the study population of 257
asthmatic children residing in Mexico City 1998-2004
Characteristic % or median
(IQR)*
Gender (%male) 63.4
Age (years) 9.0 (7.2-11.0)
Height (cm) 134 (123–145)
BMI 18.5(16.1-21.6)
Antioxidant Study participants (%) 56.0
Vitamin C intake
Supplementation group (%) 30.4
Vitamin C intake in supplementation group (mg/d) 346 (329–375)
Vitamin C intake out of supplementation group (mg/d) 105 (84–131)
Asthma severity
Moderate- and severe-persistent asthma (%) 39.3
Mild-persistent asthma (%) 24.5
Mild-intermittent asthma (%) 36.2
Atopy (%)Ϫ 83.7
Genotype and allele frequency n(%)
GSTM1 (Number of copies) †
0 93 (36.2)
1 129 (50.2)
2 35 (13.6)
GSTP1 rs1695†
Val/Val 85 (33.1)
Ile/Val 113 (44.0)
Ile/Ile 59 (22.9)
Ile/Ile+ Ile/Val 172 (66.9)
NQO1 rs1800566 ‡
Pro/Pro 67 (33.7)
Pro/Ser 88 (44.2)
Ser/Ser 44 (22.1)
Pro/Ser+ Ser/Ser 132 (66.3)
Ethnicity (%) § Mean (SD)
Native-American 70.9 (13.3)
European 26.2 (12.4)
African 2.9 (2.1)
†n = 257; ‡n = 199; § n = 160.
*Median(Q25-Q75); Ϫ Defined by skin test.
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No significant effect of ozone was observed through the
different levels of vitamin C intake.
Ozone effects by vitamin C -persistent asthmatics
Children in the lowest vitamin C intake group (≤ 105 mg/day)
and with “persistent” asthma had average decrement in
FEF25-75 per 60 ppb ozone of −61.2 ml/s (p=0.02). No sig-
nificant effect of ozone was observed with higher
vitamin C intake (Additional file 1: Table S5).
Effect of ozone on FEF25-75 stratified by genotype for
each of the three antioxidant genes and vitamin C intake
Ozone effects by genotype and vitamin C -All asthmatics
In the whole sample, children with low vitamin C intake
and with GSTM1 null genotype had the greatest average
decrement in FEF25-75 (−69.0 ml/s; p=0.07). Smaller
effects of ozone on FEF25-75 were observed in other
GSTM1-diet strata and in other GSTP1-o rNQO1-diet
combinations. The genotype effect of GSTM1 decreased as
the level of vitamin C increased (p-trend< 0.01) (Table 2).
Ozone effects by genotype and vitamin C -persistent
asthmatics
When we restricted the analysis to the “persistent”
asthma group, the effect of ozone was more pronounced
in the stratum with low vitamin C intake. The average
decrement in FEF25-75 was −91.2 ml/s (p=0.06)
(Figure 2). Children with the Val/Val GSTP1 genotype
and with low vitamin C intake had an average decrement
in FEF25-75 of −82.8 ml/s (p =0.06) per 60 ppb of ozone.
We did not find notable ozone effects on FEF25-75 in the
different strata of diet-NQO1 genotypes (Table 2).
Effect of ozone on FEF25-75 by genotype score and
vitamin C intake
Only 7 children (3.5%) had all 6 risk alleles (no GSTM1
copies, Val/Val, and Pro/Pro genotypes) and 48.3% had 4
or more risk alleles (Additional file 1: Table S1).
Ozone effects by genotype score and vitamin C -All
asthmatics
We found that among all asthmatics, the effect of ozone
on FEF25-75 in children with 4 to 6 risk alleles and low
vitamin C intake was stronger (−58.8 ml/s; p=0.07) than
in those with other gene-diet combinations (Table 3).
Ozone effects by genotype score and vitamin C -persistent
asthmatics
When we restricted the analysis to the “persistent” asthma
group, the effect of ozone in children with 4 to 6 risk
alleles and low vitamin C was even more pronounced
(−97.2 ml/s; p=0.03) than in the whole sample and
stronger than the effects on either children with 3 to 6 risk
alleles or with high level of vitamin C intake (Figure 3).
Looking at the low vitamin C intake group, the difference
between the average decrements of children with 1 to 3
risk alleles against children with 4 to 6 was −116.4 ml/s
(p=0.08). Looking at the group with 4 to 6 risk
alleles, the difference between the average decrements
of children with low against high vitamin C intake,
was 78.6 ml/s (p=0.07) Table 3.
Discussion
We found suggestive evidence that the acute effects of
ozone exposure on asthmatic children’s pulmonary func-
tion may depend on both antioxidant genes and dietary
intake of vitamin C. These ozone effects appear more
pronounced in persistent asthmatic children. In addition,
the cumulative effect of genetic susceptibility in GSTM1,
GSTP1, and NQO1 polymorphisms and low intake of
vitamin C was associated with the largest decrement in
FEF25-75 among children with persistent asthma.
GSTM1 has been most intensively studied as a deleted
versus a nondeleted dichotomous polymorphism; there
are few data using GSTM1 copy number. In this study,
we found a potential dose–response effect of GSTM1 on
the relationship between FEF25-75 and ozone exposure.
This result is consistent with the dose–response rela-
tionship between GSTM1 and the risk of lung cancer on
smokers [22].
In human lung cells, GSTP1 Val/Val genotype has
been associated with reduced GST Pi enzymatic activity
[23]. Our finding that the Val/Val may confer higher
susceptibility to ozone damage than Ile/Val or Ile/Ile
genotypes is consistent with that result. In addition,
some epidemiologic studies have reported associations
between Val/Val genotype and reduced lung function in
young adults [24] and increased risk of early onset of
asthma [25,26]. Discrepancies with other studies [27,28]
that report the Val allele as protective may be related to
ethnic differences among populations, with their conse-
quent differences in linkage disequilibrium patterns, or
due to change variation among studies.
Regarding diet, persistent asthmatics with low daily
vitamin C intake had significant decrements in FEF25–75
associated to ozone exposure, but the effect of ozone
was lessened among children with vitamin C intake over
105 mg/day. Our results suggest that persistent asth-
matic children exposed to ozone might benefit from
vitamin C intake above the RDI. Intake of >105 mg/day
was reached in our study from diet alone. This sug-
gests that children do not need to take supplements.
Consumption of daily fruits and vegetables may pro-
vide enough vitamin C for lessening the effects of ozone,
on lung function, regardless the combination of anti-
oxidant genotypes. Furthermore, fruits and vegetables
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include.
When genetic and dietary data were combined, persis-
tent asthmatics with both low vitamin C intake and
GSTM1 null or Val/Val GSTP1 had, on average, lower
levels of FEF25–75 than other children.
Although our selection of 105 mg/day as the cutoff
was based on the data distribution, it is according with
the increment of 100 mg/d suggested by some studies
for increasing about 10-50 ml in FEV1 [29].
Using our genotype score as an index of genetic
susceptibility, we found that the effect of ozone on
persistent asthmatics with less than 105 mg/day vitamin C
and with 4 to 6 risk alleles was slightly stronger than that
estimated for GSTM1 under the single gene approach in
t h es a m ed i e t a r yg r o u p( −97.2 ml/s against −91.2 ml/s
respectively). The difference between both effects was not
significant (p=0.88). This result suggests that the GSTM1
genotype alone could have been used as an indicator of
susceptibility to ozone.
As a result of environmental health policies in Mexico
City, concentrations of ozone have been reduced over
time. From 1998 to 2000 (first cohort enrollment), the
average concentrations were between 100 and 125 ppb;
Table 2 Effect of ozone on FEF25-75, according to genotype and vitamin C intake
&
Vitamin C intake
30–105 mg/day >105–226 mg/day 280-477 mg/day
Genotype n Coeff (95% CI) n Coeff (95% CI) n Coeff (95% CI)
GSTM1
All asthmatics
Null 28 −69.0 (−144.0, 6.0)£ 34 −16.2 (−66.8, 34.4) 31 −13.8 (−58.5, 30.9)
Positive 57 −12.6 (−57.3, 32.1) 60 22.2 (−23.7, 68.1) 47 6.9 (−38.9, 52.8)
Genotype effect
Ω 56.4 (−138.0, 27.0) 38.4 (−31.2,108.0) 20.7 (−43.2, 84.6) *
Persistent asthmatics
Null 17 −91.2 (−184.1, 1.7)£ 24 −23.4 (−81.0, 34.2) 24 −13.2 (−77.9, 51.5)
Positive 28 −35.4 (−102.4, 31.6) 36 −15.6 (−69.7, 38.4) 35 13.8 (−40.3, 67.9) **
Genotype effect 55.8 (56.4, -168.0) 7.8 (−114.0, 84.0) 27.0 (−57.6, 111.6)
GSTP1 rs1695
All asthmatics
Val/Val 27 −43.2 (−106.7, 20.3) 31 2.4 (−56.4, 61.2) 27 3.6 (−65.8, 73.0)
Ile/Val+Ile/Ile 58 −24.0 (−74.6, 26.6) 63 7.8 (−32.2, 47.8) 51 3.6 (−35.2, 42.4)
Genotype effect 19.2 (−68.4, 106.8) 5.4 (−65.4, 76.2) 0.0 (−79.8, 79.8)
Persistent asthmatics
Val/Val 13 −82.8 (−167.5, 1.9)£ 21 −33.0 (−104.7, 38.7) 20 18.2 (−67.8, 103.8) *
Ile/Val+Ile/Ile 32 −54.0 (−119.9, 11.9) 39 −12.0 (−59.0, 35.0) 39 0.0 (−49.4, 49.4)
Genotype effect 28.8 (−96.6, 154.2) 21.0 (−64.8, 106.8) −18.2 (−117.0, 81.0)
NQO1 rs1800566*
All asthmatics
Pro/Pro 24 −55.2 (−134.0, 23.6) 22 50.4 (−17.8, 118.6) 21 −37.8 (−114.2, 38.6)
Pro/Ser+ Ser/Ser 36 −4.8 (−62.4, 52.8) 42 −10.8 (−56.7, 35.1) 54 10.8 (−29.2, 50.8)
Genotype effect 50.4 (−45.4, -144.0) −61.2(−141.6, 192.0) 48.6 (−31.2,126.0)
Persistent asthmatics
Pro/Pro 14 −75.0 (−182.0, 32.0) 13 −0.3 (−69.7, 69.1) 19 −39.6 (−119.6, 40.4)
Pro/Ser+ Ser/Ser 23 −42.0 (−105.5, 21.5) 31 −17.4 (−70.3, 35.5) 37 17.4 (−32.0, 69.0) **
Genotype effect 33.0 (−84.0,150.0) −17.1(−111.6, 77.4) 57.0(−32.8,146.4)
Models were adjusted for gender, age, BMI, height, time, cohort, use of bronchodilator, and minimum temperature. All asthmatics: n = 257 and 4548 repeated
measures; persistent (mild, moderate, or severe) asthmatics: n = 164 and 3029 repeated measures.
*NQO1 models: all asthmatics n = 199 and 3842 repeated measures; persistent (mild, moderate, or severe): n = 137 and 2715 repeated measures. € p≤ 0.05; £ 0.05
< p< 0.1; Ω Genotype effect is defined to be the change in response produced by a change in the level of genotype.
*p-trend ≤ 0.05; ** 0.05 < p-trend < 0.1.
&FEF25-75 is reported as ml/s per 1-h 60 ppb on the day prior to spirometric test.
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concentrations were between 85 to 100 ppb [30]. When
we fit separated models by cohort, we found that in the
first cohort, the effect of ozone on children with low
vitamin C intake and GSTM1 null genotype, was −96.0;
95% CI(−204.0,12.6); whereas a lower effect was observed
in the second cohort (−20.4; 95% CI (−114.6, 73.2)). Thus,
final models were adjusted for a covariate accounting for
the cohort.
Although our focus was on FEF25-75, we also analyzed
the association between ozone and other measures of
lung function including FEV1, FVC and PEF but we did
not find any significant effect.
Regarding to the assessment of the potential con-
founding role of ethnicity, we rejected the null
hypothesis of association between Native-American
ancestry and the outcome setting an alpha-level of
0.20 instead of 0.05 level in order to insure adequate
power to detect any important confounder effect
[31]. This lack of confounder effect may be explained by
the fact that the children were recruited at the same
Public Hospital suggesting similar socioeconomic status.
Some advantages and limitations of our study need to
be addressed. Advantages include repeated measure-
ments of FEF25-75. Obtaining longitudinal measurements
of quantitative phenotypes reduces potential outcome
misclassification and increases power by focusing on
within-subject variations in outcome while controlling
for among subjects differences using random intercepts
and random slopes on time-dependent ozone exposure.
We were able to assess the potential confounding effect
of population admixture and thereby exclude any potential
confounding effect of admixture from our data. This is the
first time that the confounding role of ethnicity in the asso-
ciation between genotype and respiratory health of Mexican
asthmatic children exposed to ozone has been assessed.
Ethnicity was based on genome-wide association
genotyping. The absence of association between the
levels of FEF25-75 and ethnicity in these Mexican asthmatic
children supports the validity of previously-reported
genetic associations in this population [9,32].
Potential limitations include inaccuracy in assessment of
personal ozone exposure. Because exposure assessment
was based on monitoring stations located within 5 km from
the children’s homes, potential misclassification of exposure
is possible. However, using personal monitors on a subset
of participants in the “Antioxidants” study (n=144), a
Figure 2 Effect of ozone on FEF25-75 and 95% CI according to
genotypes and vitamin C intake. Persistently asthmatic children
with vitamin C intake between 30 to 105 mg/day and with GSTM1
null had lower levels of FEF25-75 than children with either GSTM1
positive genotype or dietary vitamin C intake higher than 105
mg/day. Similar situation was observed for Val/Val vs. Ile/Val+Ile/Ile
GSTP1 polymorphisms. Linear mixed models were adjusted for age,
gender, BMI, height, cohort, time, use of bronchodilator, and
previous day’s minimum temperature. Reported values correspond
to the effect on FEF25-75 per 60 ppb of ozone.
Table 3 Effect of ozone on FEF25-75, according to the number of risk alleles and vitamin C
&
30–105 mg/day >105–477 mg/day
Risk Alleles n Coeff (95% CI) n Coeff (95% CI) Diet effect
π
All asthmatics
1 to 3 30 24.0 (−50.0, 98.1) 73 27.0 (−16.5, 70.5) 3.0 (−82.2, 88.2)
4t o6 3 0 −58.8 (−122.3, 0.1) £ 66 −16.8 (−49.7, 16.1) 42.0(−24.0, 108.0)
Genotype effect
Ω −82.8 (−180.0, 15.0) £ −43.8 (−98.4, 11.4)
Persistent asthmatics
1 to 3 18 19.2 (−67.8, 106.2) 50 15.6 (−35.0, 66.2) −3.6 (−105.6, 98.4)
4t o6 1 9 −97.2 (−185.4,- 9.0) € 50 −18.6 (−58.6, 21.4) 78.6 (77.1, 80.1) £
Genotype effect −116.4 (−118.4, -114.4) £ −34.2 (−98.4, 30.0)
Models were adjusted for gender, age, BMI, height, chronological time, cohort, use of bronchodilator, and minimum temperature. All asthmatics: n = 199 and 3842
repeated measures; persistent (mild, moderate or severe) asthmatics: n= 137 and 2715 repeated measures.
€ p≤ 0.05; £ 0.05 < p≤0.1; Ω Genotype effect is defined to be the change in response produced by a change in the level of genotype.
Π Diet effect is defined to be the change in response produced by a change in the level of diet intake.
&FEF25-75 is reported as ml/s per 1-h 60 ppb on the day
prior to spirometric test.
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bient ozone levels was observed [33]. Based on this vali-
dation, we would expect any misclassification in exposure
to be random with the consequence of underestimating the
adverse effect of ozone.
We were not able to measure plasma vitamin C levels of
the participants but a validated food frequency question-
naire was used to estimate intake. Self-reported vitamin C
intake was adjusted for total caloric intake. Through this
adjustment, the between-person variation due to over- or
under reporting of intake is reduced and a gain in accur-
acy is potentially obtained [18,34]. Under this assumption,
we would expect any misclassification in vitamin C intake
to be random; therefore its potential protective effect may
be underestimated.
While we focused on dietary vitamin C intake, we
recognize that vitamin E has also been positively related
to lung function. Children in the highest level of vitamin
C intake had 50 mg per day of vitamin E as part of the
antioxidant supplementation. It is worthy to note that
although children in the medium level of vitamin C did
not have supplementation, they had no significant ozone
effects. Therefore, the effect of vitamin C might be pre-
dominant. Nevertheless, since both vitamin C and E may
be present in the same foods, and because the biological
interplay between them [35], part of the effect observed
for vitamin C may be related to vitamin E intake as well.
Although ozone has received a great deal of attention,
PM2.5 has also been associated with respiratory diseases.
However, since concentrations of PM2.5 in México City
only began to be registered by the network in 2000, we
were not able to analyze the effect of this pollutant.
Nevertheless, when data were available, it has been
observed that PM2.5 and ozone are correlated (r=0.46;
p<0.0001) [11]. Thus, part of the effect observed for
ozone may be related to PM2.5 exposure.
Selection bias is unlikely because those children with-
out diet or genotype information were not aware of their
individual susceptibility to ozone exposure. In addition,
included and excluded groups had similar characteris-
tics. Moreover, we used an objective measure of ozone
effect – pulmonary function.
We acknowledge that our sample size was relatively
small. Large sample sizes are required to study multi-way
interactions with complex diseases such as asthma. In
contrast, longitudinal studies of quantitative traits with
repeated measurements are more powerful than cross-
sectional studies of binary disease outcomes. Thus, despite
our modest sample size, we were able to examine effects
of ozone and diet on repeated measures analyses of the
quantitative traits of FEF25-75 in our asthmatic children.
Although we are not aware of a study with similar
design that could be used for replication, a number of
observational studies suggest that vitamin C may reduce
asthma risk and may prevent inflammatory response in
the airways by reducing reactive oxygen species [36].
Further, the intake of vitamin C and of fruits rich in vita-
min C has been positively associated to lung function
[35]. Moreover, the protective effect of high fruits and
vegetables intake has been reported as having potentially
inverse modifying influence to cigarette smoking on the
asthma risk for genetically vulnerable individuals [37]
and the antioxidant role of some genes such as GSTM1,
GSTP1, and NQO1 has been recognized [6,7,26].
Albeit reported p-values throughout this paper have not
been corrected for multiple comparisons, we believe that
it is unlikely to detect effects due to statistical fluctuations
only because of the epidemiological evidence for the
interactive effects of air pollutants with vitamin C intake
[29,35,38] and antioxidant genes [25,27,28] on asthma
symptoms and lung function.
Conclusions
We conclude that dietary vitamin C intake, either from
fruits and vegetables or supplementation provides some
protection against the effect of ozone on the pulmonary
function of asthmatic children in an area with high
ozone exposures– Mexico City. Effects of ozone were
predominantly seen in the lowest tertile of vitamin C
intake – up to 105 mg/day. Daily consumption of a slice
of papaya or pineapple and 2 oranges, for example, can
provide more than 105 mg/day of vitamin C. Dietary
modification to increase intake of fruits rich in vitamin
C is a simple intervention that is likely to have other
Figure 3 Effect of ozone on FEF25-75 and 95% CI according to
genotype score and vitamin C intake. Persistently asthmatic
children with vitamin C intake between 30 to 105 mg/day (low diet)
and with 4 to 6 risk alleles had lower levels of FEF25-75 than children
with either 1 to 3 risk alleles or dietary vitamin C intake higher than
105 mg/day (high diet). Linear mixed models were adjusted for age,
gender, BMI, height, cohort, time, use of bronchodilator, and
previous day’s minimum temperature. N=137 asthmatic children
and 2715 repeated measures.
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respiratory health of children with deficient enzymatic
activity on antioxidant genes and with low vitamin C
intake than on that of children who have adequate
enzymatic activity, vitamin C intake, or both.
Endnotes
a Normal metabolic processes in all cells are the main
endogenous sources of reactive oxygen species.
b “Emission vehicular and asthma” in Spanish.
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